Contact this trialFirst, we need to learn more about you.
Cyclin-Dependent Kinase Inhibitor
TAS-116 + Palbociclib for Advanced Breast Cancer
Recruiting1 awardPhase 1
Providence, Rhode Island
This trial studies a new drug combo to treat advanced breast cancer in patients who have not responded to palbociclib alone or have a mutated retinoblastoma gene.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.